Latest Prostate cancer screening Stories
Prostate cancer screening using the prostate-specific antigen (PSA) test is widely used in France despite a lack of evidence showing that it reduces cancer deaths.
“Irrefutable” evidence that colorectal cancer screening is effective at reducing the disease’s mortality rate should lead healthcare policymakers to shift resources currently devoted to breast and prostate cancer screenings to CRC testing.
Cancer patients can be accurately screened for major depression with a simple two-question survey.
The level of expression of three genes associated with aging can be used to predict whether seemingly low-risk prostate cancer will remain slow-growing.